BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6604941)

  • 1. Systemic lupus erythematosus and lymphoma. A family study.
    Berliner S; Shoenfeld Y; Sidi Y; Santo M; Weinberger A; Luria D; Hazaz B; Pecht M; Zaizov R; Pinkhas J
    Scand J Rheumatol; 1983; 12(3):310-4. PubMed ID: 6604941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reticulum cell sarcoma in azathioprine-treated systemic lupus erythematosus.
    Hehir ME; Sewell JR; Hughes GR
    Ann Rheum Dis; 1979 Feb; 38(1):94-5. PubMed ID: 373652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azathioprine plus prednisone compared with prednisone alone in the treatment of systemic lupus erythematosus. Report of a prospective controlled trial in 24 patients.
    Hahn BH; Kantor OS; Osterland CK
    Ann Intern Med; 1975 Nov; 83(5):597-605. PubMed ID: 1106277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatosplenic αβ T-cell lymphoma associated with azathioprine therapy.
    Rashidi A; Lee ME; Fisher SI
    Int J Hematol; 2012 May; 95(5):592-4. PubMed ID: 22527855
    [No Abstract]   [Full Text] [Related]  

  • 5. Azathioprine and prednisone in the treatment of adults with lupus nephritis. Clinical, histological, and immunological changes with therapy.
    Drinkard JP; Stanley TM; Dornfeld L; Austin RC; Barnett EV; Pearson CM; Vernier RL; Adams DA; Latta H; Gonick HC
    Medicine (Baltimore); 1970 Sep; 49(5):411-32. PubMed ID: 4924695
    [No Abstract]   [Full Text] [Related]  

  • 6. Further observations on the treatment of lupus nephritis with prednisone and combined prednisone and azathioprine.
    Donadio JV; Holley KE; Wagoner RD; Ferguson RH; McDuffie FC
    Arthritis Rheum; 1974; 17(5):573-81. PubMed ID: 4278104
    [No Abstract]   [Full Text] [Related]  

  • 7. Two chromosome aberrations in the child of a woman with systemic lupus erythematosus treated with azathioprine and prednisone.
    Ostrer H; Stamberg J; Perinchief P
    Am J Med Genet; 1984 Mar; 17(3):627-32. PubMed ID: 6711614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a lymphocytic lymphoma during immunosuppressive therapy with azathioprine for systemic lupus erythematosus with renal involvement induced by phenylbutazone.
    Walden PA; Philalithis PE; Joekes AM; Bagshawe KD
    Clin Nephrol; 1977 Jul; 8(1):317-20. PubMed ID: 577907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prednisone and azathioprine compared to prednisone plus low-dose azathioprine and cyclophosphamide in the treatment of diffuse lupus nephritis.
    Ginzler E; Diamond H; Guttadauria M; Kaplan D
    Arthritis Rheum; 1976; 19(4):693-9. PubMed ID: 782464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary malignant lymphoma of the spleen in systemic lupus erythematosus.
    Buskila D; Gladman DD; Hannah W; Kahn HJ
    J Rheumatol; 1989 Jul; 16(7):993-6. PubMed ID: 2769672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Childhood systemic lupus erythematosus. Association with pancreatitis, subcutaneous fat necrosis, and calcinosis cutis.
    Simons-Ling N; Schachner L; Penneys N; Gorman H; Zillereulo G; Strauss J
    Arch Dermatol; 1983 Jun; 119(6):491-4. PubMed ID: 6859888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience with mycophenolate mofetil as maintenance therapy in five pediatric patients with severe systemic lupus erythematosus.
    Dittrich K; Ross S; Benz K; Amann K; Dötsch J
    Klin Padiatr; 2009 Dec; 221(7):425-9. PubMed ID: 20013565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppressive therapy: guidelines for drug dosage. Depression of bone marrow granulocyte reserves in systemic lupus erythematosus.
    Paulus HE; Okun R; Calabro JJ
    Arthritis Rheum; 1972; 15(1):29-35. PubMed ID: 5059641
    [No Abstract]   [Full Text] [Related]  

  • 14. [Iatrogenic causes of death in systemic lupus erythematosus].
    Oliver JA; Carreras L; Bernheim J; Beruard M; Zech P; Traeger J
    Rev Clin Esp; 1976 Aug; 142(3):227-30. PubMed ID: 968112
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of treatment with enkorton and cytostatics on selected immunologic indicators in patients with systemic lupus erythematosus].
    Małdykowa H; Chwalińska-Sadowska H; Grabowska A; Dratwianka B; Abgarowicz-Miłkowska T; Jedryka-Góral A; Swierczyńska Z; Rdułtowska H; Luft S; Rogozińska E
    Reumatologia; 1982; 20(1-2):7-14. PubMed ID: 7163667
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunologic and clinical effects of cytotoxic drugs used in the treatment of rheumatoid arthritis and systemic lupus erythematosus.
    Fox DA; McCune WJ
    Concepts Immunopathol; 1989; 7():20-78. PubMed ID: 2676180
    [No Abstract]   [Full Text] [Related]  

  • 17. Avascular necrosis of bone in systemic lupus erythematosus.
    Bergstein JM; Wiens C; Fish AJ; Vernier RL; Michael A
    J Pediatr; 1974 Jul; 85(1):31-5. PubMed ID: 4850716
    [No Abstract]   [Full Text] [Related]  

  • 18. Autoimmune hyperlipidemia in a child with autoimmune hepatitis.
    Rumbo C; Betzhold J; Merati S; Shneider BL
    J Clin Gastroenterol; 2002 Aug; 35(2):196-9. PubMed ID: 12172368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Azathioprine in the treatment of systemic lupus erythematosus. A controlled study.
    Sztejnbok M; Stewart A; Diamond H; Kaplan D
    Arthritis Rheum; 1971; 14(5):639-45. PubMed ID: 4106177
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs.
    Austin HA; Klippel JH; Balow JE; le Riche NG; Steinberg AD; Plotz PH; Decker JL
    N Engl J Med; 1986 Mar; 314(10):614-9. PubMed ID: 3511372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.